Target intelligence / Profile preview

Prokaryotic ribosome

Molecular classification
Ribosome, Ribozymes (catalytic RNA components), Molecular machine, Other
01

Overview

The **prokaryotic ribosome** is a complex macromolecular machine found in all bacteria and archaea, responsible for translating messenger RNA (mRNA) into proteins essential for cell function and survival. It consists of two subunits—the small 30S subunit (with 16S rRNA and about 21 proteins) and the large 50S subunit (with 23S and 5S rRNA and about 31 proteins)—which together form the functional 70S ribosome. The ribosome catalyzes the assembly of amino acids into polypeptide chains using the genetic instructions encoded in mRNA, a process highly conserved across all domains of life. Owing to key structural differences between prokaryotic and eukaryotic ribosomes, the prokaryotic ribosome is a validated and highly effective target for many classes of antibiotics, which bind to specific sites to inhibit different stages of translation. Structural and biochemical studies of the 70S ribosome have been fundamental in understanding mechanisms of protein synthesis, antibiotic action, and resistance development.

Other names
70S ribosomeBacterial ribosomeProkaryote ribosome
02

Mechanism of action

Inhibition of mRNA decoding or ribosomal translocation; Disruption of peptide bond formation; Binding to ribosomal subunits to block tRNA or mRNA positioning; Interference with ribosomal exit tunnel

03

Biological functions

Protein synthesis (translation)Peptide bond formationDecoding genetic informationOther
04

Disease associations

Infection (antibiotic target)Other
05

Safety considerations

Possibility of off-target mitochondrial ribosome inhibition in humans (since mitochondria contain ribosomes similar to prokaryotes)Development of antibiotic resistanceHypersensitivity or toxicity (collateral effects of broad-spectrum antibiotics)
06

Interacting drugs

Aminoglycosides (e.g., paromomycin, gentamicin)

7 more in the full profile.

07

Biomarkers

16S rRNA sequence (for bacterial identification and patient selection in diagnostics)Mutations conferring antibiotic resistance (e.g., in 23S rRNA)

Beyond the preview

Go deeper on Prokaryotic ribosome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prokaryotic ribosome.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call